Extracellular matrix inspired surface functionalization with heparin, fibronectin and VEGF provides an anticoagulant and endothelialization supporting microenvironment
Source abstract
Abstract
Abstract The biocompatibility of currently used coronary artery stent is still far from perfect, which closely related to insufficient endothelialization and thrombus formation. In this study, heparin, fibronectin and VEGF were immobilized on Ti surface to construct a multifunctional microenvironment with favorable properties to inhibit thrombosis formation and promote endothelialization simultaneously. The microenvironment on Ti surface was characterized in detail and demonstrated that the Hep/Fn/VEGF biofunctional coating was constructed successfully on Ti surface. The influence of surface properties such as chemical composition, roughness, hydrophilicity, and binding density of biomolecules on the performances of hemocompatibility and cytocompatibility was evaluated and discussed. Modified surface significantly enhanced the AT III binding density and prolonged the clotting time. In vitro platelet adhesion and activation assays further proved that the modified surface presented favorable anti-coagulant property. In addition, the proliferation of endothelial progenitor cells (EPCs) and endothelial cells (ECs) on the Hep/Fn/VEGF biofunctional coating was significantly promoted. In conclusion, the Hep/Fn/VEGF biofunctional coating was successfully constructed with desirable anticoagulant and endothelialization supporting properties. This work may provide a promising approach for biofunctional surface modification of coronary artery stent to acquire a desired multifunctional microenvironment.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Cardiac and Coronary Surgery Techniques · Hemostasis and retained surgical items
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Management of acute coronary syndromes. Variations in practice and outcome: findings from the Global Registry of Acute Coronary Events10.1053/euhj.2001.3081 ↗
2. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin: the Euro Heart Survey of acute coronary syndromes10.1053/euhj.2002.3193 ↗
3. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device10.1016/j.jacc.2009.03.055 ↗
4. Sustained benefit at two years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting10.1161/CIRCULATIONAHA.107.688341 ↗
5. The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti Implants10.1016/j.biomaterials.2010.08.073 ↗
6. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts10.1161/CIRCULATIONAHA.108.781377 ↗
7. Coronary in-stent restenosis: current status and future strategies10.1016/S0735-1097(01)01742-9 ↗
8. Animal models of human coronary restenosis
9. Arterial remodelling after coronary angioplasty: a serial intravascular ultrasound study10.1161/01.CIR.94.1.35 ↗
10. Study on inducing of cord blood derived endothelial progenitor cells into endothelial cells
11. Research progress of endothelial progenitor cells and endothelializaiton after PTCA
12. Inducing cord blood and peripheral blood derived EPCs into endothelial cells in vitro
13. Effect of plasma energy on enhancing biocompatibility and hemocompatibility of diamond-like carbon film with various titanium concentrations10.1016/j.jallcom.2008.11.043 ↗
14. Improving the biocompatibility of titanium surface through formation of a TiO2 nano-mesh layer10.1016/j.tsf.2010.05.045 ↗
15. Controlling the drug release rate from biocompatible polymers with micro-patterned diamond-like carbon (DLC) coating10.1016/j.diamond.2010.01.053 ↗
16. Antifungal activity, biofilm-controlling effect, and biocompatibility of poly(N-vinyl-2-pyrrolidinone)-grafted denture materials10.1016/j.colsurfb.2013.04.043 ↗
17. Biocompatibility of Ti-alloys for long-term implantation10.1016/j.jmbbm.2012.11.014 ↗
18. The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts10.1016/j.biomaterials.2012.09.046 ↗
19. Chitosan and mixtures with aqueous biocompatible temperature sensitive polymer as flocculants10.1016/j.colsurfa.2012.03.048 ↗
20. Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials10.1016/j.actbio.2011.08.001 ↗
21. Effect of RGD nanospacing on differentiation of stem cells10.1016/j.biomaterials.2013.01.021 ↗
22. Oriented immobilization of anti-CD34 antibody on titanium surface for self-endothelialization induction10.1002/jbm.a.32812 ↗
23. The critical role of ECM proteins within the human MSC niche in endothelial differentiation10.1016/j.biomaterials.2013.02.062 ↗
24. Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: the role of heparin sodium salt and the PLGA-based microsphere approach10.1016/j.actbio.2013.03.013 ↗
25. Covalent immobilization of chitosan/heparin mixture with a photosensitive hetero-bifunctional crosslinking reagent on PLA surface10.1016/S0142-9612(02)00215-6 ↗
26. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility10.1016/j.biomaterials.2009.11.091 ↗
27. Covalently immobilized RGD gradient on PEG hydrogel scaffold influences cell migration parameters10.1016/j.actbio.2009.12.050 ↗
28. Fibronectin coating of collagen modules increases in vivo HUVEC survival and vessel formation in SCID mice10.1016/j.actbio.2010.11.008 ↗
29. Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses10.1016/j.biomaterials.2007.10.055 ↗
30. The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system10.1016/j.biomaterials.2008.12.075 ↗
31. 5 Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism10.1016/S0950-3536(98)80086-3 ↗
32. Anticoagulant action of heparin10.1038/246355a0 ↗
33. Inhibition of smooth muscle cell adhesion and proliferation on heparin-doped polypyrrole10.1016/j.actbio.2011.07.029 ↗
34. Human endothelial cells: use of heparin in cloning and long-term serial cultivation10.1126/science.6635659 ↗
35. Fibronectin at a glance10.1242/jcs.00059 ↗
36. Fibronectins in vascular morphogenesis10.1007/s10456-009-9136-6 ↗
37. Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi10.1182/blood-2005-10-4168 ↗
38. The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization10.1016/j.biomaterials.2011.03.025 ↗
39. Coimmobilization of heparin/fibronectin mixture on titanium surfaces and their blood compatibility10.1016/j.colsurfb.2010.07.016 ↗
40. Protein-based signaling systems in tissue engineering10.1016/j.copbio.2003.08.004 ↗
41. The effect of VEGF functionalization of titanium on endothelial cells in vitro10.1016/j.biomaterials.2009.11.042 ↗
42. Co-culture, proliferation and migration of human umbilical cord blood-derived endothelial progenitor cells with vascular endothelial growth factor and basic fibroblast growth factor
43. The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF10.1016/j.biomaterials.2009.05.030 ↗
44. Immobilization of heparin/poly-l-lysine nanoparticles on dopamine coated surface to construct heparin density gradient for selective direction of platelet and vascular cell behavior
45. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells10.1016/j.actbio.2007.12.011 ↗
46. The endothelialization and hemocompatibility of the functional multilayer on titanium surface constructed with type IV collagen and heparin10.1016/j.colsurfb.2012.12.053 ↗
47. Effect of fibronectin on the binding of antithrombin III to immobilized heparin10.1002/(SICI)1097-4636(199601)30:1<95::AID-JBM12>3.0.CO;2-P ↗
48. Effects of surface properties and bioactivation of biomaterials on endothelial cells
49. The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype10.1016/j.biomaterials.2009.08.004 ↗
50. Effect of micromagnetic field surface roughness of 316L stainless steel and NiTi alloy on blood compatibility10.1007/s11517-010-0685-z ↗
51. Platelet interactions with titanium: modulation of platelet activity by surface topography10.1016/S0142-9612(01)00009-6 ↗
52. Enhancement of the growth of human endothelial cells by surface roughness at nanometer scale10.1016/S0142-9612(03)00361-2 ↗
53. Inhibition of human endothelial cell proliferation by heparin and steroids, Cell10.1016/0309-1651(88)90028-8 ↗
54. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight10.1161/01.ATV.0000090671.56682.D7 ↗
55. Microfabrication of poly (glycerol-sebacate) for contact guidance applications10.1016/j.biomaterials.2005.11.029 ↗